Simponi Aria
Generic name: Golimumab
Drug class:
TNF alfa inhibitors
Usage of Simponi Aria
Simponi Aria is used to relieve the symptoms of certain autoimmune disorders (conditions in which the immune system attacks healthy parts of the body and causes pain, swelling, and damage) including:
Simponi Aria is a prescription medicine called a TNF-blocker (tumor necrosis factor blocker).
It is not known if Simponi Aria is safe and effective in children with PsA and pJIA under 2 years of age or in children with conditions other than PsA and pJIA.
Simponi Aria side effects
Get emergency medical help if you have signs of an allergic reaction to Simponi Aria: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
You may get infections more easily, even serious or fatal infections. Call your doctor right away if you have signs of infection such as:
Also call your doctor at once if you have:
Common Simponi Aria side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Simponi Aria
To make sure Simponi Aria is safe for you, tell your doctor if you have ever had:
Tell your doctor if you've had or been exposed to tuberculosis, or if you recently traveled. Some infections are more common in certain parts of the world, and you may have been exposed during travel.
Using Simponi Aria may increase your risk of developing other cancers. Ask your doctor about this risk.
It is not known if golimumab will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
Tell your baby's doctor if you used Simponi Aria during pregnancy. It could affect your baby's vaccination schedule during the first 6 months of life.
Ask a doctor if it is safe to breastfeed while using Simponi Aria.
Relate drugs
- Abrilada
- Avsola
- AVSOLA (Infliximab Intravenous)
- AVSOLA (Infliximab-axxq Intravenous)
- Cyltezo
- Certolizumab
- Cimzia
- Golimumab
- Hadlima
- Hulio
- Hyrimoz
- Idacio
- Inflectra
- Inflectra (Infliximab Intravenous)
- Inflectra (Infliximab-dyyb Intravenous)
- Ixifi (Infliximab Intravenous)
- Ixifi (Infliximab-qbtx Intravenous)
- Renflexis
- Renflexis (Infliximab Intravenous)
- Renflexis (Infliximab-abda Intravenous)
- Simponi
- Simponi Aria
- Simponi SmartJect
- Yuflyma
- Yusimry
How to use Simponi Aria
Usual Adult Dose of Simponi Aria for Psoriatic Arthritis:
IV: 2 mg/kg over 30 minutes at weeks 0 and 4, then every 8 weeks thereafter.
Usual Adult Dose of Simponi Aria for Rheumatoid Arthritis:
IV: 2 mg/kg over 30 minutes at Weeks 0 and 4, then every 8 weeks thereafter Use: For the treatment of patients with moderately to severely active rheumatoid arthritis
Usual Adult Dose of Simponi Aria for Ankylosing Spondylitis:
IV: 2 mg/kg over 30 minutes at weeks 0 and 4, then every 8 weeks thereafter Comments: -This drug may be given with or without methotrexate or other nonbiologic disease modifying antirheumatic drugs (DMARDs). -Corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), and/or analgesics may be continued during therapy. -Patients should be tested for hepatitis B viral infection before starting treatment. -Evaluate patients for active tuberculosis and tested for latent infection before starting treatment. -The safety and efficacy of switching between suBCutaneous and IV formulations have not been established. Use: For the treatment of patients with active ankylosing spondylitis (AS)
Usual Pediatric Dose of Simponi Aria for Psoriatic Arthritis:
IV: 80 mg/m2 over 30 minutes at weeks 0 and 4, and every 8 weeks thereafter Comments: -Dosage regimen is based on body surface area (BSA). Use: For the treatment of active psoriatic arthritis in patients 2 years of age and older
Usual Pediatric Dose of Simponi Aria for Juvenile Idiopathic Arthritis:
IV: 80 mg/m2 over 30 minutes at weeks 0 and 4, and every 8 weeks thereafter Comments: -Dosage regimen is based on body surface area (BSA). Use: For the treatment of active polyarticular juvenile idiopathic arthritis (pJIA) in patients 2 years of age and older
Warnings
You should not use Simponi Aria if you are also using abatacept or anakinra.
Simponi Aria affects your immune system. You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, chills, aches, tiredness, cough, skin sores, diarrhea, or burning when you urinate.
Serious and sometimes fatal infections may occur during treatment with Simponi Aria, especially if you also use other medications that can weaken your immune system.
If you have ever had tuberculosis or hepatitis B, Simponi Aria can cause these conditions to come back or get worse. You should be tested for these conditions before you start using Simponi Aria.
Some people using Simponi Aria have developed a rare fast-growing type of lymphoma (cancer) that affects the liver, spleen, and bone marrow, and it can be fatal. This has occurred mostly in teenage boys and young men using Simponi Aria.
What other drugs will affect Simponi Aria
Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use, which may increase side effects or make the medicines less effective.
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may interact with golimumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions